26 October 2021
From the heart: Pandemic no barrier for medtech’s ASX listing
Amid a biotech boom, see how Artrya, an aussie medtech company, is pioneering the detection and assessment of the underlying cause of heart attack. Globally, we will change how the world sees coronary artery disease.